Skip to main content

Table 2 The main pharmacokinetic parameters of seven lignan components after SCE gavage in rats (x ± s, n = 6)

From: Schisandrin protects against ulcerative colitis by inhibiting the SGK1/NLRP3 signaling pathway and reshaping gut microbiota in mice

Parameters

Schisandrin

Schisandrol B

Deoxyschizandrin

Schizandrin B

Schizandrin C

Schisanhenol

Schisantherin A

T1/2(h)

1.68 ± 0.26

3.30 ± 0.55

4.19 ± 0.50

4.49 ± 0.02

7.15 ± 4.48

6.84 ± 2.62

5.18 ± 3.24

Tmax(h)

2.00 ± 0.00

2.00 ± 0.00

2.67±1.16

2.00 ± 0.00

2.00 ± 0.00

4.00 ± 0.00

2.67 ± 1.16

Cmax(ng/ml)

1078.54 ± 179.30

182.43 ± 19.98

136.74 ± 45.83

183.43 ± 66.96

24.65 ± 9.03

85.31 ± 8.10

75.81 ± 34.20

MRT0-∞(h)

4.54 ± 0.70

5.75 ± 0.46

6.23 ± 0.77

9.03 ± 0.34

9.94 ± 4.56

11.09 ± 2.83

8.24 ± 1.24

CL(L/h/kg)

4.62 ± 1.22

7.43 ± 2.02

9.68 ± 3.25

5.41 ± 1.47

10.17 ± 3.73

1.35 ± 0.18

1.25 ± 0.26

V(L/kg)

11.14 ± 3.19

1419.21 ± 412.19

59.85 ± 25.71

35.04 ± 9.69

90.87 ± 28.97

12.93 ± 3.67

8.71 ± 3.71

AUC0-t(ng.h/ml)

5774.32 ± 1456.47

1419.21 ± 412.19

946.23 ± 379.15

1615.77 ± 439.42

195.09 ± 87.05

1115.96 ± 160.10

672.45 ± 139.56

AUC0-∞(ng.h/ml)

5775.05 ± 1457.02

1431.21 ± 410.25

960.14 ± 380.61

1627.57 ± 440.60

224.67 ± 129.91

1160.33 ± 205.58

709.09 ± 189.60